Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Lack of Flvcr2 impairs brain angiogenesis without affecting the blood-brain barrier
Nicolas Santander, … , Christer Betsholtz, Thomas D. Arnold
Nicolas Santander, … , Christer Betsholtz, Thomas D. Arnold
Published May 5, 2020
Citation Information: J Clin Invest. 2020;130(8):4055-4068. https://doi.org/10.1172/JCI136578.
View: Text | PDF
Research Article Angiogenesis Development

Lack of Flvcr2 impairs brain angiogenesis without affecting the blood-brain barrier

  • Text
  • PDF
Abstract

Fowler syndrome is a rare autosomal recessive brain vascular disorder caused by mutation in FLVCR2 in humans. The disease occurs during a critical period of brain vascular development, is characterized by glomeruloid vasculopathy and hydrocephalus, and is almost invariably prenatally fatal. Here, we sought to gain insights into the process of brain vascularization and the pathogenesis of Fowler syndrome by inactivating Flvcr2 in mice. We showed that Flvcr2 was necessary for angiogenic sprouting in the brain, but surprisingly dispensable for maintaining the blood-brain barrier. Endothelial cells lacking Flvcr2 had altered expression of angiogenic factors, failed to adopt tip cell properties, and displayed reduced sprouting, leading to vascular malformations similar to those seen in humans with Fowler syndrome. Brain hypovascularization was associated with hypoxia and tissue infarction, ultimately causing hydrocephalus and death of mutant animals. Strikingly, despite severe vascular anomalies and brain tissue infarction, the blood-brain barrier was maintained in Flvcr2 mutant mice. Our Fowler syndrome model therefore defined the pathobiology of this disease and provided new insights into brain angiogenesis by showing uncoupling of vessel morphogenesis and blood-brain barrier formation.

Authors

Nicolas Santander, Carlos O. Lizama, Eman Meky, Gabriel L. McKinsey, Bongnam Jung, Dean Sheppard, Christer Betsholtz, Thomas D. Arnold

×

Figure 3

Angiogenesis is impaired by Flvcr2 inactivation.

Options: View larger image (or click on image) Download as PowerPoint
Angiogenesis is impaired by Flvcr2 inactivation.
(A) Genes involved in s...
(A) Genes involved in sprouting angiogenesis that were differentially expressed in endothelial cells lacking Flvcr2 are shown. n = 4 per genotype. (B) scRNA-Seq data from ref. 27 were reanalyzed (see Methods) to show expression levels of Dll4, Flt4, and Esm1 in endothelial cells from hypoxic brains. These genes were most highly expressed in a cluster unique to the hypoxic brain (cluster 5, indicated by arrows). (C) Protein levels of angiogenic proteins were evaluated by Western blot in brain vascular fragments from E15.5 embryos. *P < 0.05; **P < 0.01, t test. n = 8 per genotype. (D) Selected proteins were detected by immunofluorescence (shown in black over white background) in sections through the LGE at E14.5. Scale bar: 200 μm. (E) Fluorescence intensity of the selected proteins in isolectin-B4+ cells was quantified. **P < 0.01, t test. n = 7 per genotype.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts